Search

CN-121971489-A - Disinfectant, disinfectant wet tissue and application

CN121971489ACN 121971489 ACN121971489 ACN 121971489ACN-121971489-A

Abstract

The invention relates to the technical field of disinfection, in particular to a disinfectant, a disinfection wet tissue and application. The invention provides a disinfectant, which comprises nano silver, a compound quaternary ammonium salt and matrine extracting solution, wherein the compound quaternary ammonium salt is a mixture of single-chain quaternary ammonium salt and double-chain quaternary ammonium salt. The disinfectant provided by the invention is composed of nano silver, matrine extract and composite quaternary ammonium salt formed by mixing single-chain quaternary ammonium salt and double-chain quaternary ammonium salt, and the disinfectant wet tissue prepared by using the disinfectant can efficiently kill HIV, influenza A virus, bacteria and fungi, has lasting antifungal, bacterial and viral effects, no stimulation to mucous membrane, and is safe and durable.

Inventors

  • SUN HAITAO

Assignees

  • 海涛生物科技(浙江)有限公司

Dates

Publication Date
20260505
Application Date
20251201

Claims (10)

  1. 1. A disinfectant is characterized by comprising the following components of nano silver, composite quaternary ammonium salt and matrine extract; the compound quaternary ammonium salt is a mixture of single-chain quaternary ammonium salt and double-chain quaternary ammonium salt.
  2. 2. The disinfectant according to claim 1, wherein the mass ratio of the single-chain quaternary ammonium salt to the double-chain quaternary ammonium salt in the composite quaternary ammonium salt is 1.0:0.5-2, preferably 1.0:0.8-1.4; the extraction method of the matrine extract is ethanol extraction.
  3. 3. The disinfectant according to claim 1, wherein the content of nano silver is 5-10mg/L, the content of single-chain quaternary ammonium salt is 0.005-0.02wt%, the content of double-chain quaternary ammonium salt is 0.005-0.02wt%, and the content of matrine extract is 3-5vol%.
  4. 4. The disinfectant according to claim 1, wherein the single-chain quaternary ammonium salt comprises at least one of dodecyl dimethyl benzyl ammonium chloride, dodecyl dimethyl benzyl ammonium bromide, cetyl trimethyl ammonium chloride, cetyl trimethyl ammonium bromide; The double-chain quaternary ammonium salt comprises at least one of didecyl dimethyl ammonium chloride, didecyl dimethyl ammonium bromide, dioctyl dimethyl ammonium chloride and dioctyl dimethyl ammonium bromide.
  5. 5. The sanitizing solution of claim 1, further comprising ethanol, a surfactant, and a solubilizing agent.
  6. 6. The sanitizing solution of claim 5, wherein said surfactant comprises at least one of polysorbate 80 or polyoxyethylated castor oil; The solubilizing agent comprises at least one of ethylene glycol or propylene glycol.
  7. 7. The disinfectant according to claim 5, wherein the ethanol content is 11.25-15v/v%, the surfactant content is 1-2v/v%, and the solubilizer content is 0.5-1v/v%, based on the total weight of the disinfectant.
  8. 8. A disinfectant wet wipe comprising the disinfectant of any of claims 1-7.
  9. 9. The disinfectant wet wipe of claim 8, wherein the ratio of disinfectant to nonwoven substrate is from 3.0 to 3.5:1 in mL g; The non-woven fabric base material comprises 40-45wt% of viscose and 55-60wt% of terylene based on the total weight of the non-woven fabric base material.
  10. 10. Use of a disinfectant as claimed in any one of claims 1 to 7 or a disinfectant wet wipe as claimed in any one of claims 8 to 9 for anti-hiv, anti-influenza a, anti-bacterial and anti-fungal.

Description

Disinfectant, disinfectant wet tissue and application Technical Field The invention relates to the technical field of disinfection, in particular to a disinfectant, a disinfection wet tissue and application. Background With the advent of new pathogens and drug-resistant bacteria, scientific, precise disinfection strategies will become more important. Traditional disinfectant, while effective against bacteria and some viruses, is not durable and safe. Among them, AIDS (acquired immunodeficiency syndrome, AIDS) is a serious infectious disease caused by Human Immunodeficiency Virus (HIV), which is mainly transmitted through blood, sexual contact and mother and infant. In the fields of medical treatment, nursing, personal hygiene, etc., prevention of transmission of HIV virus is of great importance. Because the HIV virus has extremely strong infectivity and latency, and the outer envelope protein can be specifically combined with host cells so as to invade the immune system, effective disinfection measures are of great significance for blocking the virus transmission chain. At present, in order to inhibit transmission of human immunodeficiency virus, a disinfectant is mostly prepared by mixing a low-concentration sodium hypochlorite solution and alcohol, wherein the sodium hypochlorite damages a virus protein structure through oxidation, and the alcohol can dissolve a virus lipid envelope to lose infection capability, however, the conventional disinfectant has limited inactivation effect on human immunodeficiency virus, and especially in the presence of organic matters (such as blood or body fluid), the disinfection efficiency is further reduced. In addition, HIV virus may form biofilms in certain environments, enhancing its resistance to external disinfectants, making it difficult for conventional disinfection means to thoroughly inactivate the virus. In order to improve the disinfection effect, halogen substances such as chlorine or iodine are added into the disinfection solution in the prior art, and the strong oxidizing property of the disinfection solution is utilized to enhance the capability of killing HIV viruses. However, such substances are not only highly corrosive, but also may cause damage to medical devices, skin and mucous membranes, and may cause environmental pollution after long-term use. Meanwhile, although the disinfectant can reduce the viral load in a short time, the disinfectant has shorter action time and can not provide lasting protection effect. Disclosure of Invention Therefore, the invention aims to overcome the defects of poor safety and durability of the disinfectant in the prior art, thereby providing the disinfectant, the disinfectant wet tissue and the application. Therefore, the invention provides the following technical scheme: a disinfectant solution comprises nano silver, compound quaternary ammonium salt and matrine extract. The compound quaternary ammonium salt is a mixture of single-chain quaternary ammonium salt and double-chain quaternary ammonium salt. The mass ratio of the single-chain quaternary ammonium salt to the double-chain quaternary ammonium salt in the composite quaternary ammonium salt is 1.0:0.5-2, and preferably 1.0:0.8-1.4. The extraction method of the matrine extract is ethanol extraction. The nano silver content is 5-10mg/L, the single-chain quaternary ammonium salt content is 0.005-0.02wt%, the double-chain quaternary ammonium salt content is 0.005-0.02wt%, and the matrine extract content is 3-5vol%. The single-chain quaternary ammonium salt comprises at least one of dodecyl dimethyl benzyl ammonium chloride, dodecyl dimethyl benzyl ammonium bromide, hexadecyl trimethyl ammonium chloride and hexadecyl trimethyl ammonium bromide. The double-chain quaternary ammonium salt comprises at least one of didecyl dimethyl ammonium chloride, didecyl dimethyl ammonium bromide, dioctyl dimethyl ammonium chloride and dioctyl dimethyl ammonium bromide. The disinfectant also comprises ethanol, a surfactant and a solubilizer. The surfactant comprises at least one of polysorbate 80 or polyoxyethylated castor oil. The solubilizing agent comprises at least one of ethylene glycol or propylene glycol. The content of the ethanol is 11.25-15v/v%, the content of the surfactant is 1-2v/v%, and the content of the solubilizer is 0.5-1v/v%, based on the total weight of the disinfectant. The invention also provides a disinfection wet tissue, which comprises the disinfection solution. The ratio of the disinfectant to the non-woven fabric substrate is 3.0-3.5:1, and the unit is mL/g. The non-woven fabric base material comprises 40-45wt% of viscose and 55-60wt% of terylene based on the total weight of the non-woven fabric base material. The invention also provides an application of the disinfectant or the disinfectant wet tissue in resisting HIV, influenza A virus, bacteria and fungi. The technical scheme of the invention has the following advantages: 1. The invention provides a disin